This report contains market size and forecasts of Hepatitis Viruses Diagnostic Tests in Global, including the following market information:
- Global Hepatitis Viruses Diagnostic Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Hepatitis Viruses Diagnostic Tests market was valued at 3031.9 million in 2021 and is projected to reach US$ 3971.9 million by 2028, at a CAGR of 3.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Enzyme Immunoassay (EIA) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis Viruses Diagnostic Tests include Hologic Inc, Siemens AG, MedMira Inc., Inovio Pharmaceuticals, Inc., GenMark Diagnostics Inc, Goodgene Inc, Abbott Laboratories and Orangelife, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis Viruses Diagnostic Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis Viruses Diagnostic Tests Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis Viruses Diagnostic Tests Market Segment Percentages, by Type, 2021 (%)
- Enzyme Immunoassay (EIA)
- Recombinant Immunoblot Assay (RIBA)
- Transcription-Mediated Amplification (TMA)
- Polymerase Chain Reaction (PCR)
- Others
Global Hepatitis Viruses Diagnostic Tests Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis Viruses Diagnostic Tests Market Segment Percentages, by Application, 2021 (%)
Global Hepatitis Viruses Diagnostic Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatitis Viruses Diagnostic Tests Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Hepatitis Viruses Diagnostic Tests revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Hepatitis Viruses Diagnostic Tests revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Hologic Inc
- Siemens AG
- MedMira Inc.
- Inovio Pharmaceuticals, Inc.
- GenMark Diagnostics Inc
- Goodgene Inc
- Abbott Laboratories
- Orangelife
